Boston Scientific’s acquisition of NxThera obviously signals an end of one era. The 10-year-old start-up will live inside the global giant, of course, but we ask CEO
Bob Paulson what the sale means to him on a personal level. Paulson also walks us through his unorthodox career in marketing, corporate law, accounting, and finally leading a highly successful Medtech Start-Up.
J. Robert Paulson
President & CEO
NxThera
Bob Paulson is president, CEO and a director of NxThera, Inc., a venture-funded medical device company that developed and commercialized its convective water vapor energy technology platform to treat enlarged prostates and other endourology conditions. In March of 2018, Boston Scientific announced an agreement to acquire NxThera following receipt of applicable regulatory approvals. Bob joined NxThera in 2009 after serving as President, CEO and a Director of Restore Medical from 2005 until the company’s acquisition by Medtronic in July of 2008. Bob served as CFO and VP of Global Marketing for Endocardial Solutions, which was acquired by St. Jude Medical in 2005, the Sr. VP/General Manager of Advanced Bionics and several executive positions with Medtronic, including VP/General Manager of the Surgical Navigation Technologies business, VP Corporate Strategy and Director of Corporate Development. Bob held senior positions in marketing, corporate development, legal and finance at General Mills and practiced corporate, M&A and securities law with the Minneapolis law firm of Lindquist & Vennum. Bob currently serves as a director of Veran Medical and Sun BioPharma, and has been a director of several privately-held and public medical devices companies and charitable foundations, and is a member of the Luther College Board of Regents.
